Measuring Transparency to Improve Good Governance in the Public Pharmaceutical Sector: Syrian Arab Republic
WHO Regional Office for the Eastern Mediterranean
WHO Regional Office for the Eastern Mediterranean
ISBN-13    9789290216520 ISBN-10    9290216522
Order Number    14600050 Format    Paper Back
Price    CHF    15.00 / US$    18.00 Developing countries:    CHF    10.50
English     2009        98   pages
Table of contents
Related Publications
Translation(s) available
   Add to your order
In recent years, countries of the WHO Eastern Mediterranean Region have made significant achievements in the provision of health services. In the pharmaceutical field, countries have been striving to improve the structures and regulations pertaining to medicines and have progressed in many ways. However, there are still important challenges. The goal of the WHO Good Governance for Medicines programme is to improve the situation of medicines regulation and supply. National transparency assessment is the beginning of a process aimed at bringing about desirable and sustainable changes in the governance of the pharmaceutical sector. These reports present the findings of the first phase of the national Good Governance for Medicines programme in Jordan, Lebanon, Morocco, Pakistan and Syrian Arab Republic.